MRNA: Nilai perusahaan marang bathi resik Moderna Inc

Lambang korporat lan logo Moderna Inc (MRNA)

Moderna, Inc. (MRNA) is currently optimizing its production resources to offset the decline in pandemic-related revenues. The business relies on significant cash reserves, demonstrating resilience to crises amid seasonal demand. The company's P/E ratio clearly illustrates the asset value dynamics, with the current figure standing at -36.00. Strict regulatory requirements and patent protection for RNA technologies ensure a high barrier to entry in this niche.

Rasio rega marang bathi Moderna Inc (MRNA): kanggo periode 04.07.2022 - 12.11.2026

Rincian metrik komprehensif lan analitis Moderna Corp (MRNA)

- rega lan prakiraan konsensus rega:
Rega saham modernatx.com|MRNA - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Moderna, Inc.|MRNA - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Saham Moderna|MRNA - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku modernatx.com|MRNA - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Utang Agregat marang Ekuitas Moderna, Inc.|MRNA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Moderna Therapeutics|MRNA - Gunggung utang perusahaan|Utang marang nilai buku Moderna, Inc.|MRNA - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Moderna|Koefisien jangkoan perantara modernatx.com
- rincian bathi lan kelipatan pasar:
MRNA - Bathi resik perusahaan|Bathi resik sing dikarepake Moderna, Inc.|MRNA - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Moderna Inc|MRNA - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Moderna, Inc.|MRNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Moderna|MRNA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan modernatx.com|MRNA - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Moderna, Inc.
Ringkesan analisis perusahaan:MRNA modernatx.com
Produk sing diprodhuksi Moderna

The P/E ratio reflects the relationship between the market value of Moderna, Inc. (MRNA) and its net income, reacting to any fluctuations in operational efficiency. This metric measures the market's willingness to pay a premium for every dollar of earnings, determining the extent of the asset's fundamental overvaluation. For Moderna, Inc. (MRNA), this balance is critical due to massive R&D expenditures in oncology and genetics. Analyzing the company's consolidated P/E allows for an assessment of business resilience during the transformation of its product portfolio.

Perusahaan pesaing

Pangali P/E summittxinc.com|Koefisien rega marang bathi PCVX (Vaxcyte)|TARS (Tarsus Pharmaceuticals Inc) - Nilai perusahaan marang bathi resik|Pangali P/E CRMD (CorMedix Corp)|Periode bali modal bisnis Seres Therapeutics, Inc (MCRB)|SPRO - Rasio rega marang bathi|SCYX (SCYNEXIS, Inc.) - Pangali rega marang bathi|ANTX: Pangali P/E|Kapitalisasi marang bathi resik PYPD (PolyPid)|LSB (YS Biopharma) - Pangali P/E|Kapitalisasi marang bathi Iterum Therapeutics, plc ITRM|Pangali P/E PHGE|Koefisien rega marang bathi soligenix.com SNGX|60 Degrees Pharmaceuticals, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik OGEN (oragenics.com)|OpGen Corp - Pangali P/E